(Q36609835)

15 August 2017

1 reference

title

Skin cancer chemoprevention with systemic retinoids: an adjunct in the management of selected high-risk patients (English)

1 reference

15 August 2017

1 reference

Ross M Campbell

1

1 reference

15 August 2017

John J DiGiovanna

series ordinal

2

1 reference

15 August 2017

publication date

1 September 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

19

1 reference

15 August 2017

issue

5

1 reference

15 August 2017

page(s)

306-314

1 reference

Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00088.X

Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00088.X

SERMs in chemoprevention of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00088.X

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00088.X

Incremental costs of enrolling cancer patients in clinical trials: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00088.X

A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00088.X

A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00088.X

Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00088.X

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00088.X

The psychology of hair loss and its implications for patient care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00088.X

Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00088.X

Skin cancers after organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00088.X

Retinoids to prevent skin cancer in organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00088.X

Acitretin for chemoprevention of non-melanoma skin cancers in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00088.X

Retinoid chemoprevention in the high-risk patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00088.X

Nevoid basal cell carcinoma syndrome: combined etretinate and surgical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00088.X

Aromatic retinoid in the chemoprevention of the progression of nevoid basal-cell carcinoma syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00088.X

Isotretinoin effects on bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00088.X

10.1111/J.1529-8019.2006.00088.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference